Where can I buy shares of BNTC?
Shares of BNTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
How much did BNTC raise in its IPO?
(BNTC) raised $0 in an initial public offering on Thursday, August 6th 2015. The company issued 0 shares at a price of $0.00 per share. BMO Capital Markets and Maxim Group LLC served as the underwriters for the IPO and Roth Capital Partners was co-manager.
What is the price targets for Benitec Biopharma's stock?
The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts' consensus price target of $10.00, Benitec Biopharma has a forecasted upside of 325.5% from its current price of $2.35.
Is BNTC a good stock to buy?
BNTC has a Quality Grade of F, ranking ahead of 1.09% of graded US stocks.
What happened Benitec Biopharma?
The redomiciliation was approved by Benitec shareholders at a Scheme Meeting held on 26 March 2020, and approved by the Supreme Court of Queensland on 30 March 2020. Benitec Biopharma is now the sole shareholder in the company and is the ultimate parent company of the group.
Should I buy or sell Benitec Biopharma stock right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Benitec Biopharma in the last year. There are currently 1 buy rating for t...
What is Benitec Biopharma's stock price forecast for 2022?
1 brokerages have issued 1 year target prices for Benitec Biopharma's stock. Their forecasts range from $10.00 to $10.00. On average, they expect B...
How has Benitec Biopharma's stock performed in 2022?
Benitec Biopharma's stock was trading at $2.62 at the beginning of the year. Since then, BNTC shares have decreased by 65.6% and is now trading at...
Are investors shorting Benitec Biopharma?
Benitec Biopharma saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 8,000 shares, an increase...
When is Benitec Biopharma's next earnings date?
Benitec Biopharma is scheduled to release its next quarterly earnings announcement on Monday, September 19th 2022. View our earnings forecast for...
How were Benitec Biopharma's earnings last quarter?
Benitec Biopharma Inc. (NASDAQ:BNTC) posted its quarterly earnings results on Monday, May, 16th. The biotechnology company reported ($0.40) earning...
Who are Benitec Biopharma's key executives?
Benitec Biopharma's management team includes the following people: Dr. Jerel A. Banks M.D. , Ph.D., CEO & Exec. Chairman (Age 47, Pay $697.69k)...
Who are some of Benitec Biopharma's key competitors?
Some companies that are related to Benitec Biopharma include ASLAN Pharmaceuticals (ASLN) , Aptinyx (APTX) , Edesa Biotech (EDSA) , Cumberland...
What other stocks do shareholders of Benitec Biopharma own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Benitec Biopharma investors own include Amarin (AMRN) , P...
Who sold BNTC stock?
What is the BNTC symbol?
BNTC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc..
What is the P/E ratio of Benitec Biopharma?
Benitec Biopharma trades on the NASDAQ under the ticker symbol "BNTC."
What is MarketBeat community ratings?
The P/E ratio of Benitec Biopharma is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What is Benitec Biopharma?
MarketBeat's community ratings are surveys of what our community members think about Benitec Biopharma and other stocks. Vote “Outperform” if you believe BNTC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BNTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
When will Benitec Biopharma release its earnings?
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy and chronic hepatitis B virus infection. The company was founded in 1995 and is headquartered in Hayward, California.
Does Benitec pay dividends?
Benitec Biopharma is scheduled to release its next quarterly earnings announcement on Wednesday, September 22nd 2021. View our earnings forecast for Benitec Biopharma.
Who is the CEO of Benitec Biopharma?
Benitec Biopharma does not currently pay a dividend.
Is Benitec Biopharma (NASDAQ:BNTC) In A Good Position To Invest In Growth?
Jerel Banks became the CEO of Benitec Biopharma Inc. ( NASDAQ:BNTC ) in 2018, and we think it's a good time to look at...
How long are futures trading delayed?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
What is Benitec Biopharma?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
What is dividend percentage?
Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The firms proprietary platforms includes DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy...
How to calculate restricted stock?
A company's dividend expressed as a percentage of its current stock price.
What are some similar stocks to Benitec Biopharma?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. Dividend Yield.
What is Benitec Biopharma?
If you're looking for stocks that are quantitatively similar to Benitec Biopharma Inc, a group of peers worth examining would be EQS, CALT, INMB, TFFP, and LUMO.
